Compare AU
Compare DRUG vs. ERTH
Compare shares and ETFs on the ASX that you can trade on Pearler.
Overview
When it comes to investing in the Australian stock market, Exchange-Traded Funds (ETFs) are a popular choice. Two well-known options in the Australian Securities Exchange (ASX) are the BetaShares Global Healthcare ETF - Currency Hedged (DRUG) and the Solactive Climate Change Innovation (ERTH). In this comparison, we'll delve into these ETFs across various dimensions to help you make an informed investment decision.
Community Stats
DRUG | ERTH | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 63 | 372 |
Median incremental investment | $967.00 | $601.32 |
Median investment frequency | Monthly | Monthly |
Median total investment | $1,875.72 | $933.24 |
Average age group | 26 - 35 | 26 - 35 |
Key Summary
DRUG | ERTH | |
|---|---|---|
Strategy | DRUG.AX was created on 2016-08-04 by BetaShares. The fund's investment portfolio concentrates primarily on health care equity. DRUG.AX aims to track the performance of an index (before fees and expenses) that comprises the largest global healthcare companies (ex-Australia), hedged into Australian dollars. | ERTH.AX was created on 2021-03-09 by BetaShares. The fund's investment portfolio concentrates primarily on total market equity. ERTH.AX aims to track the performance of an index (before fees and expenses) that comprises a portfolio of up to 100 leading global companies that derive at least 50% of their revenues from products and services that help to address climate change and other environmental problems through the reduction or avoidance of CO2 emissions. |
Top 3 holdings | CHF - SWISS FRANC (0 %) AUD - AUSTRALIA DOLLAR (0 %) DKK - DANISH KRONE (0 %) | CIE DE SAINT-GOBAIN (5.14 %) ECOLAB INC (5.08 %) DSM-FIRMENICH AG (4.97 %) |
Top 3 industries | Other (75.53 %) Communication Services (33.53 %) Health Care (24.47 %) | Other (56.07 %) Information Technology (10.82 %) Consumer Discretionary (9.83 %) |
Top 3 countries | United States (71.71 %) Switzerland (8.14 %) Denmark (6.30 %) | United States (40.06 %) China (11.65 %) Denmark (7.67 %) |
Management fee | 0.57 % | 0.55 % |
Key Summary
DRUG | ERTH | |
|---|---|---|
Issuer | BetaShares | BetaShares |
Tracking index | Nasdaq Global ex-Australia Healthcare Hedged AUD Index - AUD | Solactive Climate Change and Environmental Opportunities Index - AUD - Benchmark TR Net |
Asset class | ETF | ETF |
Management fee | 0.57 % | 0.55 % |
Price | $8.12 | $9.24 |
Size | $191.120 million | $98.112 million |
10Y return | N/A | N/A |
Annual distribution yield (5Y) | 1.90 % | 0.58 % |
Market | ASX | ASX |
First listed date | 08/08/2016 | 10/03/2021 |
Purchase fee | $6.50 | $6.50 |
Community Stats
DRUG | ERTH | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 63 | 372 |
Median incremental investment | $967.00 | $601.32 |
Median investment frequency | Monthly | Monthly |
Median total investment | $1,875.72 | $933.24 |
Average age group | 26 - 35 | 26 - 35 |
Pros and Cons
DRUG | ERTH | |
|---|---|---|
Pros |
|
|
Cons |
|
|
DRUG | ERTH |
|---|---|
Higher exposure to US market | Lower exposure to US market |
Higher management fee | Lower management fee |
Higher price growth | Lower price growth |
Higher distribution yield | Lower distribution yield |